Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin and Saxagliptin Tablets

Glenmark  Pharmaceuticals  Inc.,  USA  (Glenmark)  has  been  granted tentativeapproval by the United States Food & Drug Administration (U.S. FDA) for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg, the generic versionof Qtern®1Tablets, 10 mg/5 mg, of AstraZeneca AB.

source https://www.pharmatutor.org/pharma-news/2020/glenmark-pharmaceuticals-receives-anda-tentative-approval-for-dapagliflozin-and-saxagliptin-tablets